1 TAMSULOSIN HCL | 160 of 1240 | 7110 prescriptions Less than 1% of all prescriptions | 6130 | 1900 patients 32% of all patients | 1650 patients 28% of all patients | |
2 FINASTERIDE | 150 of 1120 | 5020 prescriptions Less than 1% of all prescriptions | 4850 | 1270 patients 21% of all patients | < 11 | |
3 MYRBETRIQ (MIRABEGRON) | 50 of 910 | 2570 prescriptions Less than 1% of all prescriptions | 2170 | 620 patients 10% of all patients | < 11 | |
4 ALFUZOSIN HCL ER (ALFUZOSIN HCL) | 120 of 550 | 910 prescriptions Less than 1% of all prescriptions | | 240 patients 4% of all patients | < 11 | |
5 BICALUTAMIDE | 40 of 470 | 1070 prescriptions Less than 1% of all prescriptions | | 260 patients 4% of all patients | < 11 | |
6 DUTASTERIDE | 80 of 520 | 850 prescriptions Less than 1% of all prescriptions | 710 | 170 patients 3% of all patients | < 11 | |
7 OXYBUTYNIN CHLORIDE ER (OXYBUTYNIN CHLORIDE) | 370 of 880 | 880 prescriptions Less than 1% of all prescriptions | | 230 patients 4% of all patients | < 11 | |
8 POTASSIUM CITRATE ER (POTASSIUM CITRATE) | 30 of 560 | 760 prescriptions Less than 1% of all prescriptions | 600 | 130 patients 2% of all patients | < 11 | |
9 NITROFURANTOIN (NITROFURANTOIN MACROCRYSTAL) | 110 of 510 | 830 prescriptions Less than 1% of all prescriptions | 720 | 200 patients 3% of all patients | < 11 | A |
10 DOXAZOSIN MESYLATE | 130 of 380 | 410 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
11 OXYBUTYNIN CHLORIDE | 410 of 760 | 220 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
12 ESTRADIOL | 60 of 160 | 270 prescriptions Less than 1% of all prescriptions | | 130 patients 2% of all patients | < 11 | |
13 VESICARE (SOLIFENACIN SUCCINATE) | 210 of 660 | 310 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
14 ESTRACE (ESTRADIOL) | 60 of 210 | 210 prescriptions Less than 1% of all prescriptions | | 150 patients 2% of all patients | < 11 | |
15 IMIPRAMINE HCL | 70 of 170 | 280 prescriptions Less than 1% of all prescriptions | 280 | < 11 | < 11 | |
16 CIALIS (TADALAFIL) | 80 of 250 | 260 prescriptions Less than 1% of all prescriptions | 150 | < 11 | < 11 | |
17 TESTOSTERONE CYPIONATE | 240 of 510 | 240 prescriptions Less than 1% of all prescriptions | 130 | < 11 | < 11 | |
18 ALLOPURINOL | 150 of 310 | 170 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
19 RENACIDIN (CITRIC AC/GLUCONOLACT/MAG CARB) | 20 of 40 | 150 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
20 CLOTRIMAZOLE-BETAMETHASONE (CLOTRIMAZOLE/BETAMETHASONE DIP) | 30 of 170 | 350 prescriptions Less than 1% of all prescriptions | | 180 patients 3% of all patients | < 11 | |
21 CIPROFLOXACIN HCL | 280 of 820 | 790 prescriptions Less than 1% of all prescriptions | | 570 patients 10% of all patients | < 11 | A |
22 ZYTIGA (ABIRATERONE ACETATE) | 30 of 40 | 180 prescriptions Less than 1% of all prescriptions | 180 | < 11 | < 11 | |
23 TOVIAZ (FESOTERODINE FUMARATE) | 160 of 330 | 170 prescriptions Less than 1% of all prescriptions | 170 | < 11 | < 11 | |
24 PREDNISONE | 40 of 40 | 130 prescriptions Less than 1% of all prescriptions | 130 | < 11 | < 11 | |
25 ZOLPIDEM TARTRATE | 10 | 120 prescriptions Less than 1% of all prescriptions | 120 | < 11 | < 11 | |
26 HYDROCODONE-ACETAMINOPHEN (HYDROCODONE/ACETAMINOPHEN) | 110 of 750 | 970 prescriptions Less than 1% of all prescriptions | 800 | 780 patients 13% of all patients | 630 patients 10% of all patients | O |
27 SULFAMETHOXAZOLE-TRIMETHOPRIM (SULFAMETHOXAZOLE/TRIMETHOPRIM) | 460 of 930 | 280 prescriptions Less than 1% of all prescriptions | | 240 patients 4% of all patients | < 11 | A |
28 NITROFURANTOIN MONO-MACRO (NITROFURANTOIN MONOHYD/M-CRYST) | 510 of 770 | 140 prescriptions Less than 1% of all prescriptions | 140 | < 11 | < 11 | A |
29 OXYCODONE-ACETAMINOPHEN (OXYCODONE HCL/ACETAMINOPHEN) | 220 of 520 | 230 prescriptions Less than 1% of all prescriptions | | 210 patients 4% of all patients | < 11 | O |
30 DIAZEPAM | 70 of 150 | 220 prescriptions Less than 1% of all prescriptions | | 190 patients 3% of all patients | < 11 | |